Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php |
Title | Invectys - Cancer |
Description | Mission and Contact us Facebook Google+ Twitter LinkedIn Home Company Mission and vision About Invectys Inc. Board of Directors Strategic Advisors Scientific Advisory |
Keywords | N/A |
WebSite | invectys.com |
Host IP | 213.186.33.19 |
Location | France |
Site | Rank |
US$3,108,757
Last updated: 2022-06-21 16:08:19
invectys.com has Semrush global rank of 3,404,674. invectys.com has an estimated worth of US$ 3,108,757, based on its estimated Ads revenue. invectys.com receives approximately 358,703 unique visitors each day. Its web server is located in France, with IP address 213.186.33.19. According to SiteAdvisor, invectys.com is safe to visit. |
Purchase/Sale Value | US$3,108,757 |
Daily Ads Revenue | US$2,870 |
Monthly Ads Revenue | US$86,089 |
Yearly Ads Revenue | US$1,033,064 |
Daily Unique Visitors | 23,914 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
invectys.com. | A | 1799 | IP: 213.186.33.19 |
invectys.com. | NS | 10800 | NS Record: ns-68-a.gandi.net. |
invectys.com. | NS | 10800 | NS Record: ns-147-b.gandi.net. |
invectys.com. | NS | 10800 | NS Record: ns-200-c.gandi.net. |
invectys.com. | MX | 600 | MX Record: 10 filter3963.zerospam.ca. |
invectys.com. | MX | 600 | MX Record: 30 filter999.zerospam.ca. |
invectys.com. | MX | 600 | MX Record: 20 filter3964.zerospam.ca. |
invectys.com. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
invectys.com. | TXT | 300 | TXT Record: MS=ms42061068 |
Contact us Facebook Google+ Twitter LinkedIn Home Company Mission and vision About Invectys Inc. Board of Directors Strategic Advisors Scientific Advisory Board Senior Management Team Technology HLA-G Telomerase DNA Vaccination Products & pipeline Invectys’ pipeline IVS-1001 – Anti-cancer peptide vaccine IVS-2001 – A DNA vaccine targeting cancer HLA-G platform IVS-3001 – anti-HLA-G CAR T cells IVS-4001 – anti-HLA-G Monoclonal Antibodies IVS-5001 – the anti-ILT4 Nanobody Resources Glossary Invectys publications News Press Releases Events Contact Contact us Careers Home Company Mission and vision About Invectys Inc. Board of Directors Strategic Advisors Scientific Advisory Board Senior Management Team Technology HLA-G Telomerase DNA Vaccination Products & pipeline Invectys’ pipeline IVS-1001 – Anti-cancer peptide vaccine IVS-2001 – A DNA vaccine targeting cancer HLA-G platform IVS-3001 – anti-HLA-G CAR T cells IVS-4001 – anti-HLA-G Monoclonal Antibodies IVS-5001 – the anti-ILT4 Nanobody |
HTTP/1.1 403 Forbidden date: Sat, 23 Oct 2021 18:12:48 GMT content-type: text/html; charset=iso-8859-1 server: Apache x-iplb-request-id: D17E5643:A4A4_D5BA2113:0050_617450A0_1218:2CA58 x-iplb-instance: 30832 |
Domain Name: INVECTYS.COM Registry Domain ID: 1582621744_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.gandi.net Registrar URL: http://www.gandi.net Updated Date: 2020-11-17T18:55:50Z Creation Date: 2010-01-21T15:28:54Z Registry Expiry Date: 2022-01-21T15:28:54Z Registrar: Gandi SAS Registrar IANA ID: 81 Registrar Abuse Contact Email: abuse@support.gandi.net Registrar Abuse Contact Phone: +33.170377661 Domain Status: ok https://icann.org/epp#ok Name Server: NS-147-B.GANDI.NET Name Server: NS-200-C.GANDI.NET Name Server: NS-68-A.GANDI.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T04:12:19Z <<< |